In vitro PLK1 inhibition by BI 2536 decreases proliferation and induces cell-cycle arrest in melanoma cells.
de Oliveira, Jaqueline Carvalho
In vitro PLK1 inhibition by BI 2536 decreases proliferation and induces cell-cycle arrest in melanoma cells. [electronic resource] - Journal of drugs in dermatology : JDD May 2012 - 587-92 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1545-9616
Antineoplastic Agents--administration & dosage
Cell Cycle Proteins--antagonists & inhibitors
Cell Line, Tumor
Cell Proliferation--drug effects
Disease Progression
Dose-Response Relationship, Drug
G2 Phase Cell Cycle Checkpoints--drug effects
Humans
M Phase Cell Cycle Checkpoints--drug effects
Melanoma--drug therapy
Protein Serine-Threonine Kinases--antagonists & inhibitors
Proto-Oncogene Proteins--antagonists & inhibitors
Pteridines--administration & dosage
Skin Neoplasms--drug therapy
Polo-Like Kinase 1
In vitro PLK1 inhibition by BI 2536 decreases proliferation and induces cell-cycle arrest in melanoma cells. [electronic resource] - Journal of drugs in dermatology : JDD May 2012 - 587-92 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1545-9616
Antineoplastic Agents--administration & dosage
Cell Cycle Proteins--antagonists & inhibitors
Cell Line, Tumor
Cell Proliferation--drug effects
Disease Progression
Dose-Response Relationship, Drug
G2 Phase Cell Cycle Checkpoints--drug effects
Humans
M Phase Cell Cycle Checkpoints--drug effects
Melanoma--drug therapy
Protein Serine-Threonine Kinases--antagonists & inhibitors
Proto-Oncogene Proteins--antagonists & inhibitors
Pteridines--administration & dosage
Skin Neoplasms--drug therapy
Polo-Like Kinase 1